Redmile Group, LLC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 39 filers reported holding ATYR PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2018$1,715,000
-65.7%
1,884,9920.0%0.06%
-69.9%
Q1 2018$4,995,000
-24.4%
1,884,992
-0.1%
0.19%
-32.8%
Q4 2017$6,604,000
-30.7%
1,886,7920.0%0.29%
-38.9%
Q3 2017$9,528,0001,886,7920.47%
Other shareholders
ATYR PHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$18,755,00012.78%
EcoR1 Capital, LLC 840,462$8,623,0003.92%
Rock Springs Capital Management LP 388,996$3,991,0000.32%
SPHERA FUNDS MANAGEMENT LTD. 209,027$2,145,0000.27%
Baker Brothers Advisors 2,335,125$23,958,0000.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 461,530$4,735,0000.18%
TIVERTON ASSET MANAGEMENT LLC 472,236$4,845,0000.11%
RS INVESTMENT MANAGEMENT CO LLC 1,082,249$11,104,0000.10%
RIVERHEAD CAPITAL MANAGEMENT LLC 415,377$4,262,0000.07%
Magnetar Financial LLC 354,659$3,639,0000.05%
View complete list of ATYR PHARMA INC shareholders